AlphaMark Advisors, LLC
- SEC CIK
- 0001348183
- Latest filing
- Jan 21, 2025
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q4 2024 holdings
- Shares (Q4 2024)
- 38,461
- Value
- $73.0K
- % of portfolio
- <0.1%
- Quarters held
- 1
- Since Q4 2024